PURPLE BIOTECH
Kitov Pharmaceuticals is an innovative biopharmaceutical drug development company. Leveraging deep regulatory and clinical-trial expertise, Kitov's veteran team of healthcare professionals maintains a proven track record in streamlined end-to-end drug development and approval. The company was founded in 2010 and is headquartered in Tel Aviv, Israel.
PURPLE BIOTECH
Industry:
Biotechnology Health Care Pharmaceutical Therapeutics
Founded:
2010-06-01
Address:
Tel Aviv, Tel Aviv, Israel
Country:
Israel
Website Url:
http://www.purple-biotech.com
Total Employee:
1+
Status:
Active
Contact:
+972-3-9333121
Email Addresses:
[email protected]
Total Funding:
51 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS
Similar Organizations
Topmunnity Therapeutics
Topmunnity Therapeutics is an oncology focused drug development company.
Current Employees Featured
Founder
Stock Details
Key Employee Changes
| Date | New article |
|---|---|
| 2022-07-14 | Purple Biotech Announces Executive Leadership Changes |
Official Site Inspections
http://www.purple-biotech.com Semrush global rank: 4.03 M Semrush visits lastest month: 3.05 K
- Host name: 55.253.208.35.bc.googleusercontent.com
- IP address: 35.208.253.55
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Purple Biotech"
Investors - Purple Biotech
4 days ago Purple Biotech Ltd.โs Board of Directors sets high standards for the Companyโs employees, officers and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of โฆSee details»
Purple Biotech GmbH
Purple Biotech (NASDAQ:PPBT) is an innovative, clinical stage, oncology-focused company. We provide cancer patients with first-in-class, effective, and durable therapies by overcoming tumor immune evasion and drug resistance. โฆSee details»
CORPORATE PRESENTATION - purple-biotech.com
Purple Biotech (NASDAQ/TASE: PPBT) As of June 30, 2024 โข ADS Outstanding: 29.0 M โข Cash Balance: $7.3 M โข Additional $2 M raised in July 2024 Strong position to reach short and mid โฆSee details»
Purple Biotech - Crunchbase Company Profile & Funding
Organization. Purple Biotech . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Purple Biotech is an innovative โฆSee details»
Purple Biotech Ltd (PPBT) Company Profile & Overview - Stock โฆ
Nov 20, 2024 Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. โฆSee details»
Purple Biotech Completes Patient Enrollment in Phase 2 Pancreatic ...
Dec 14, 2023 Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug โฆSee details»
Purple Biotech Ltd (PPBT)
Purple Biotech Ltd., a clinical-stage company, focuses on developing therapies to overcome tumor immune evasion and drug resistance for cancer patients in the United States. Its โฆSee details»
Purple Biotech (PPBT) Stock Price, News & Analysis
4 days ago Purple Biotech has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower โฆSee details»
Press viewer - Purple Biotech
Nov 15, 2024 New data regarding Purple Biotech's novel tri-specific antibody platform, CAPTN-3, were presented at the 36th European Organization for Research and Treatment of Cancer, โฆSee details»
Purple Biotech to Present Data for its Tri-Specific Antibody โฆ
Oct 10, 2024 About Purple Biotech Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune โฆSee details»
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell โฆ
Oct 25, 2024 Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug โฆSee details»
Purple Biotech Ltd (PPBT) - Yahoo Finance
Find the latest Purple Biotech Ltd (PPBT) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
Purple Biotech Presents New Data for its Novel Tri-Specific T Cell โฆ
Purple Biotech Ltd. CAPTN-3 demonstrates sustained tumor regression in a triple negative breast cancer in-vivo model; A dose dependent activity and a synergistic effect of the engager arms โฆSee details»
Purple Biotech Reports Preclinical Proof of Concept for its Tribody ...
Mar 14, 2024 Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug โฆSee details»
Purple Biotech Completes Patient Enrollment in Phase 2 ... - Nasdaq
Dec 14, 2023 --Purple Biotech Ltd., a clinical-stage company developing first-in-class therapies that harness the power of the tumor microenvironment to overcome tumor immune evasion โฆSee details»
CORPORATE PRESENTATION - Purple Biotech
Purple Biotech (NASDAQ/TASE: PPBT) CM24 -First in class ฮฑCEACAM1 mAb, Validating clinical collaboration with NT219 - First-in-class, small molecule, dual inhibitor of IRS 1/2 and STAT3 โฆSee details»
Purple Biotech Reports Additional Positive Interim Results from its ...
Jun 27, 2024 Purple Biotech Ltd. New data suggests that b aseline serum myeloperoxidase (MPO) levels below the threshold may predict overall survival (OS) improvement when โฆSee details»
Purple Biotech Presents New Data for its Novel Tri ... - Morningstar
Oct 25, 2024 Purple Biotech Ltd. (NASDAQ/TASE: PPBT) is a clinical-stage company developing first-in-class therapies that seek to overcome tumor immune evasion and drug โฆSee details»
Pipeline - Purple Biotech
Oct 25, 2024 A Phase 1 2 Study with Open Label, Dose Escalation Phase Followed by Single Arm Expansion at the Maximum Tolerated Dose to Assess the Safety, Tolerability, โฆSee details»